U.S. Biological Sample Collection Kits Market Analysis

U.S. Biological Sample Collection Kits Market Analysis

Based on product, the U market is categorized into swabs, viral transport media, blood collection kits, urine collection kits, and other products. The swabs segment generated the highest revenue of USD 695.2 million in 2023.
 

• The significant volume of testing required for disease surveillance, contact tracing, and public health initiatives ensures a sustained and large-scale demand for swabs.
   
• Additionally, swabs are essential for collecting samples to diagnose various infectious diseases beyond COVID-19, such as influenza, respiratory syncytial virus (RSV), strep throat, and other respiratory infections.
   

Based on application, the U.S. biological sample collection kits market is classified into diagnostics, and research. The diagnostics segment dominated the market in 2023 with a market share of 69%.
 

• The continuous need to diagnose and monitor infectious diseases, including COVID-19, influenza, HIV, tuberculosis, and other bacterial or viral infections, drives significant demand for diagnostic testing.
   
• Furthermore, advances in diagnostic technologies, such as point-of-care testing (POCT), molecular diagnostics, and rapid tests, have made diagnostics more accessible and efficient. These technologies often require specialized sample collection kits and increase their demand in the market.
   

Based on end-use, the U.S. biological sample collection kits market is classified into hospitals and clinics, diagnostic centers, homecare, and other end-users. The hospitals and clinics segment dominated the market and is expected to grow at a pace of 7.6% CAGR between 2024 – 2032.
 

• Hospitals and clinics perform a broad spectrum of diagnostic testing, including blood testing, urine testing, swab testing, tissue biopsies, and more. This comprehensive range of services necessitates a constant supply of diverse sample collection kits.
   
• Moreover, in emergency and critical care settings, rapid diagnostic testing is essential. Hospitals, with their emergency departments and intensive care units (ICUs), require reliable and quick sample collection methods to diagnose and treat patients promptly, increasing their demand in these facilities.